Immunoreactive neurotensin levels in pancreas: Elevation in diabetic rats and mice

Madelyn Hirsch Fernstrom, Marek A Mirski, Robert E. Carraway, Susan E. Leeman

Research output: Contribution to journalArticle

Abstract

Neurotensin levels in pancreas, but not other tissues, were increased in diabetic animals. The concentration of pancreatic immunoreactiveneurotensin was 138% higher in streptozotocin-diabetic rats, and 68% higher in genetically diabetic ( db db) mice as compared to their respective control animals. Daily administration of insulin (10-15 IU/kg) to diabetic rats completely reversed this effect, and pancreatic neurotensin levels in these animals returned to control values. These findings suggest that elevated levels of pancreatic neurotensin may contribute to some of the metabolic and hormonal disturbances occurring in diabetes.

Original languageEnglish (US)
Pages (from-to)853-855
Number of pages3
JournalMetabolism
Volume30
Issue number9
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Neurotensin
Pancreas
Streptozocin
Insulin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Immunoreactive neurotensin levels in pancreas : Elevation in diabetic rats and mice. / Fernstrom, Madelyn Hirsch; Mirski, Marek A; Carraway, Robert E.; Leeman, Susan E.

In: Metabolism, Vol. 30, No. 9, 1981, p. 853-855.

Research output: Contribution to journalArticle

Fernstrom, Madelyn Hirsch ; Mirski, Marek A ; Carraway, Robert E. ; Leeman, Susan E. / Immunoreactive neurotensin levels in pancreas : Elevation in diabetic rats and mice. In: Metabolism. 1981 ; Vol. 30, No. 9. pp. 853-855.
@article{8269dede74334fdd8a7e8f1da060de5a,
title = "Immunoreactive neurotensin levels in pancreas: Elevation in diabetic rats and mice",
abstract = "Neurotensin levels in pancreas, but not other tissues, were increased in diabetic animals. The concentration of pancreatic immunoreactiveneurotensin was 138{\%} higher in streptozotocin-diabetic rats, and 68{\%} higher in genetically diabetic ( db db) mice as compared to their respective control animals. Daily administration of insulin (10-15 IU/kg) to diabetic rats completely reversed this effect, and pancreatic neurotensin levels in these animals returned to control values. These findings suggest that elevated levels of pancreatic neurotensin may contribute to some of the metabolic and hormonal disturbances occurring in diabetes.",
author = "Fernstrom, {Madelyn Hirsch} and Mirski, {Marek A} and Carraway, {Robert E.} and Leeman, {Susan E.}",
year = "1981",
doi = "10.1016/0026-0495(81)90063-9",
language = "English (US)",
volume = "30",
pages = "853--855",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Immunoreactive neurotensin levels in pancreas

T2 - Elevation in diabetic rats and mice

AU - Fernstrom, Madelyn Hirsch

AU - Mirski, Marek A

AU - Carraway, Robert E.

AU - Leeman, Susan E.

PY - 1981

Y1 - 1981

N2 - Neurotensin levels in pancreas, but not other tissues, were increased in diabetic animals. The concentration of pancreatic immunoreactiveneurotensin was 138% higher in streptozotocin-diabetic rats, and 68% higher in genetically diabetic ( db db) mice as compared to their respective control animals. Daily administration of insulin (10-15 IU/kg) to diabetic rats completely reversed this effect, and pancreatic neurotensin levels in these animals returned to control values. These findings suggest that elevated levels of pancreatic neurotensin may contribute to some of the metabolic and hormonal disturbances occurring in diabetes.

AB - Neurotensin levels in pancreas, but not other tissues, were increased in diabetic animals. The concentration of pancreatic immunoreactiveneurotensin was 138% higher in streptozotocin-diabetic rats, and 68% higher in genetically diabetic ( db db) mice as compared to their respective control animals. Daily administration of insulin (10-15 IU/kg) to diabetic rats completely reversed this effect, and pancreatic neurotensin levels in these animals returned to control values. These findings suggest that elevated levels of pancreatic neurotensin may contribute to some of the metabolic and hormonal disturbances occurring in diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0019403346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019403346&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(81)90063-9

DO - 10.1016/0026-0495(81)90063-9

M3 - Article

C2 - 6455583

AN - SCOPUS:0019403346

VL - 30

SP - 853

EP - 855

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 9

ER -